Hematology / the Education Program of the American Society of Hematology
about
The incidence, natural history, biology, and treatment of transformed lymphomasStandard therapy of advanced Hodgkin lymphomaThe hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disordersNew ways to use DNA methyltransferase inhibitors for the treatment of myelodysplastic syndromeMany multiple myelomas: making more of the molecular mayhemFuture prospects for contact factors as therapeutic targetsFLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Emerging Therapies: Spectrum of Applications of Monoclonal Antibody TherapyChronic myeloproliferative disordersHam-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosisUpdate on cobalamin, folate, and homocysteineManagement of polycythemia vera and essential thrombocythemiaPlatelets and thrombosis in myeloproliferative diseasesThe cardiovascular pharmacology of COX-2 inhibitionThrombosis and the antiphospholipid syndromeAtypical cellular disordersWorld health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variantsMyelodysplastic/myeloproliferative neoplasmsAlpha thalassemia major--new mutations, intrauterine management, and outcomesGaucher disease and other storage disordersParamount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphomaRed cell membrane disordersSolitary bone and extramedullary plasmacytomaPrognosis of myelodysplastic syndromesChildhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemiaAtypical Cellular DisordersUpdate on Cobalamin, Folate, and HomocysteineHam-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and ApoptosisWhat to do after the bleed: resuming anticoagulation after major bleeding.Role of stem cell transplant and maintenance therapy in plasma cell disorders.What have we learned from large population studies of von Willebrand disease?T-cell acute lymphoblastic leukemia.Primary central nervous system lymphoma.Risk stratification and management of acute pulmonary embolism.Minimal residual disease in mantle cell lymphoma: insights into biology and impact on treatment.Cellular immune responses in red blood cell alloimmunization.Transplantation for myelodysplastic syndromes: who, when, and which conditioning regimens.Prognostic factors in follicular lymphoma: new tools to personalize risk.Sequencing of chronic lymphocytic leukemia therapies.Acute promyelocytic leukemia: preventing early complications and late toxicities.
P1433
Q22299209-54BD6062-26AB-46EC-81EC-8EA20267E669Q22299211-293ED5FA-4E86-4B3A-8037-889A532B8916Q26823465-E4B4F859-597C-4DEA-806F-03707DE32B17Q26829132-D092AB66-0A8E-416E-913E-33CB158E45C0Q26852892-6830540E-6D7F-48BB-B4A0-7EBDF6E58829Q26865096-ACE4FE5A-5775-4DFD-AD9B-86FF211DF46EQ27028163-9D2DC745-CDA6-4F52-9C58-7C835AD82C61Q28109596-A336E4B8-97B5-4C14-A909-417921426A5EQ28166225-ACE7A0FE-F45B-45FF-9938-ADFFCE09C057Q28186440-4FF4C63E-7B14-48A2-AC5F-11E9E5D6A6F4Q28186446-E3A0B09B-8DA3-4D5B-B4A9-7A080CBBD9D4Q28193505-25615E9B-3B98-4A72-A295-7F553D0F32A3Q28193508-65521DFE-98D1-4DE9-A8A0-1FC90496D15BQ28193511-F6FD38AD-C897-45C6-8B3D-2321A40F3A6BQ28193514-A1D8CA1B-2EB2-42B3-9003-DFE5ECB68E70Q28215721-A4265F4E-7CAE-4A91-BC86-750D5D046B85Q28255225-48BA45D1-51D7-4E8B-8332-555CCFF072E1Q28255235-519C7AFA-2957-4F3F-A837-55D27B474BA1Q28267607-7EA1A2C3-7DE3-49FA-84DE-BED0C7E0A98EQ28281290-88A2A8B4-2134-4EA7-83C7-854110578E08Q28281302-6839C41A-288A-4FF6-9307-E49E89D479C6Q28283155-130666D2-92CA-42BC-8989-1EBD9CFF9ADAQ28283166-20925FD9-4D54-4D9C-9AAE-1F1412CC5CB6Q28303407-A6FCAAD8-9063-4EEF-8D32-0CA9881D0D97Q28303417-A224AAB6-A5C1-43E5-B462-99E0534FE6FCQ29037720-5B79D742-884F-429D-BAA9-AF30BF9899E1Q29391662-A21ED76E-AF43-4B86-B8FF-7E916D162B2BQ29542235-52D8693C-649C-40F5-AC24-93F2566C984BQ30240179-091F76AB-216C-4D3C-AC76-7E70DDFF2716Q30240206-4F65EF2A-88D0-4055-9978-65871234360AQ30240214-A3E0D560-2747-4B8E-97C0-77C776488C91Q30240217-44E2898D-F0B7-4ABF-B0BA-1518644F2643Q30240222-4581FD36-85A6-485A-9DFD-CEBE6CF982BCQ30240225-7036D93F-7CC3-4AA5-8F1A-89F3FF66F62DQ30240227-FFBF0AC9-BA53-43AA-966E-7BAB6AC1A1C4Q30240230-DE35F598-FCB3-4C5E-B325-A03109C48D8EQ30240238-366872CD-783C-4D87-85D9-9D6FBF2492C7Q30240241-5D9807C9-9A6F-437F-BB3D-DE1E3E3FDDB5Q30240243-417D0E22-FC97-4178-BA62-B6CE3B9EF45EQ30240249-2A816D40-BFB1-4286-95BE-047B9522F93B
P1433
Hematology / the Education Program of the American Society of Hematology
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Hematology / the Education Program of the American Society of Hematology
@ast
Hematology / the Education Program of the American Society of Hematology
@en
Hematology / the Education Program of the American Society of Hematology
@es
Hematology / the Education Program of the American Society of Hematology
@it
Hematology / the Education Program of the American Society of Hematology
@nl
type
label
Hematology / the Education Program of the American Society of Hematology
@ast
Hematology / the Education Program of the American Society of Hematology
@en
Hematology / the Education Program of the American Society of Hematology
@es
Hematology / the Education Program of the American Society of Hematology
@it
Hematology / the Education Program of the American Society of Hematology
@nl
altLabel
Hematology online (ASH)
@en
prefLabel
Hematology / the Education Program of the American Society of Hematology
@ast
Hematology / the Education Program of the American Society of Hematology
@en
Hematology / the Education Program of the American Society of Hematology
@es
Hematology / the Education Program of the American Society of Hematology
@it
Hematology / the Education Program of the American Society of Hematology
@nl
P31
P3181
P1055
P1156
P236
P3181
P571
2000-01-01T00:00:00Z